Clever Leaves Holdings Inc
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowe… Read more
Clever Leaves Holdings Inc (CLVRW) - Net Assets
Latest net assets as of March 2024: $24.22 Million USD
Based on the latest financial reports, Clever Leaves Holdings Inc (CLVRW) has net assets worth $24.22 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($31.24 Million) and total liabilities ($7.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $24.22 Million |
| % of Total Assets | 77.51% |
| Annual Growth Rate | -16.66% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 72.82 |
Clever Leaves Holdings Inc - Net Assets Trend (2019–2023)
This chart illustrates how Clever Leaves Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Clever Leaves Holdings Inc (2019–2023)
The table below shows the annual net assets of Clever Leaves Holdings Inc from 2019 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $24.22 Million | -40.07% |
| 2022-12-31 | $40.41 Million | -44.47% |
| 2021-12-31 | $72.77 Million | -36.34% |
| 2020-12-31 | $114.31 Million | +127.74% |
| 2019-12-31 | $50.19 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Clever Leaves Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16687100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $223.02 Million | 920.93% |
| Total Equity | $24.22 Million | 100.00% |
Clever Leaves Holdings Inc Competitors by Market Cap
The table below lists competitors of Clever Leaves Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cargills PLC
CM:CARGN0000
|
$24.57K |
|
COTY-A
BE:CO3A
|
$24.57K |
|
MICHAEL PAGE INT
BE:3MI
|
$24.58K |
|
Kidpik Corp
NASDAQ:PIK
|
$24.58K |
|
Eagon Industrial Co. Ltd.
KQ:008250
|
$24.53K |
|
BELLINI NAUTICA S.P.A.
F:F2F
|
$24.52K |
|
WHARF (HLDGS)
MU:WHA
|
$24.50K |
|
ZAMBIA SUGAR PLC
LUSE:ZSUG
|
$24.49K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Clever Leaves Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 40,408,000 to 24,217,000, a change of -16,191,000 (-40.1%).
- Net loss of 17,899,000 reduced equity.
- New share issuances of 1,340,000 increased equity.
- Other factors increased equity by 368,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.90 Million | -73.91% |
| Share Issuances | $1.34 Million | +5.53% |
| Other Changes | $368.00K | +1.52% |
| Total Change | $- | -40.07% |
Book Value vs Market Value Analysis
This analysis compares Clever Leaves Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $174.66 | $0.02 | x |
| 2020-12-31 | $137.82 | $0.02 | x |
| 2021-12-31 | $84.98 | $0.02 | x |
| 2022-12-31 | $31.57 | $0.02 | x |
| 2023-12-31 | $15.45 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Clever Leaves Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -73.91%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -102.77%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 1.29x
- Recent ROE (-73.91%) is above the historical average (-88.44%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -105.78% | -614.37% | 0.08x | 2.10x | $-52.68 Million |
| 2020 | -36.23% | -341.78% | 0.07x | 1.45x | $-52.85 Million |
| 2021 | -62.71% | -296.81% | 0.13x | 1.60x | $-52.91 Million |
| 2022 | -163.58% | -371.35% | 0.34x | 1.29x | $-70.14 Million |
| 2023 | -73.91% | -102.77% | 0.56x | 1.29x | $-20.32 Million |
Industry Comparison
This section compares Clever Leaves Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Clever Leaves Holdings Inc (CLVRW) | $24.22 Million | -105.78% | 0.29x | $24.53K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |